Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Invest. 2008 Aug;118(8):2684-6. doi: 10.1172/JCI36552.

Marking a path to transplant tolerance.

Author information

  • 1Department of Medicine, University of California, San Francisco, San Francisco, California, USA. vseyfert@immunetolerance.org

Erratum in

  • J Clin Invest. 2008 Sep;118(9):3240.


Long-term allograft survival requires lifelong immunosuppression, which comes with serious side effects. Inducing immune tolerance to the transplant would enable immunosuppression withdrawal and revolutionize the quality of life of transplant recipients. In this issue of the JCI, Martínez-Llordella et al. identify a profile of biomarkers that predict tolerance in liver transplant recipients (see the related article beginning on page 2845). These findings translate into a new means for prospectively selecting liver transplant patients who would benefit from immunosuppression withdrawal and ultimately may guide development of tolerogenic therapies that allow for allograft acceptance without the use of long-term immunosuppression.

Comment on

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Journal of Clinical Investigation Icon for PubMed Central
    Loading ...
    Write to the Help Desk